Sales & Marketing Key payer backs Ultragenyx' rare rickets drug at $200,000 pe... Express Scripts' Miller backs "responsible" price
News FDA unveils fast-track review path for 'national priorities' FDA Commissioner Marty Makary has revealed a new priority review voucher programme for new medicines deemed to be of national priority for the US.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
